What is the recommended treatment for dry, irritated eyes using Systane (Polyethylene Glycol 400 0.4% and Propylene Glycol 0.3%)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Systane for Dry, Irritated Eyes

Systane (Polyethylene Glycol 400 0.4% and Propylene Glycol 0.3%) is an effective first-line treatment for mild to moderate dry eye disease, providing temporary relief of burning and irritation through its lubricating and tear film-stabilizing properties. 1

Indications and Mechanism

  • Systane is FDA-approved for temporary relief of burning and irritation due to dryness of the eye, discomfort from minor irritations, and protection against further irritation 1
  • The formulation contains hydroxypropyl-guar, a pH-sensitive gelling agent that adapts viscosity to the ocular surface pH, becoming more viscous when the eye is drier and providing enhanced surface protection 2, 3
  • The product reduces ocular surface friction and acts as a mucomimetic, preventing surface desiccation beyond simple rewetting 2

Dosing and Administration

  • Instill 1-2 drops in the affected eye(s) as needed throughout the day 1
  • For contact lens wearers with dryness, apply twice daily: 10 minutes before lens insertion and after lens removal 4
  • When using artificial tears more than four times daily, preservative-free formulations like Systane Complete PF are strongly recommended to avoid ocular surface toxicity 5, 6

Clinical Efficacy

  • Systane provides immediate symptom relief that is sustained for up to 8 hours following a single application 7
  • The product demonstrates efficacy across all dry eye subtypes: aqueous-deficient, evaporative, and mixed 7
  • Median improvement in dry eye symptom scores ranges from -1.0 at immediate post-dose to -2.0 at 8 hours post-application 7
  • Contact lens wearers using Systane show significant increases in comfortable wear time and end-of-day comfort compared to no treatment 4

Integration into Stepwise Dry Eye Management

  • For mild dry eye: Systane serves as appropriate first-line therapy alongside environmental modifications (humidifying air, avoiding drafts, lowering computer screens below eye level) 5, 6
  • For moderate dry eye: If Systane alone is insufficient after 2-4 weeks, advance to anti-inflammatory agents such as cyclosporine 0.05% or lifitegrast 5% while continuing artificial tear supplementation 5, 6
  • Concurrent treatment of blepharitis or meibomian gland dysfunction is essential, as these conditions exacerbate dry eye and limit artificial tear efficacy 5, 6

Formulation Selection

  • Standard Systane contains polyethylene glycol 400 and propylene glycol with hydroxypropyl-guar 3
  • Systane Ultra offers enhanced symptom relief through optimized gelling properties 8, 3
  • Systane Balance includes lipid components specifically designed for patients with meibomian gland dysfunction and evaporative dry eye 3
  • Systane Complete PF provides preservative-free formulation in single-use vials for patients requiring frequent dosing 1

Common Pitfalls to Avoid

  • Do not use preserved formulations more than four times daily, as preservatives cause cumulative ocular surface toxicity that worsens dry eye 5, 6
  • Failing to recognize when symptoms persist despite adequate artificial tear use (typically after 2-4 weeks) delays necessary escalation to anti-inflammatory therapy 6
  • Neglecting to address underlying blepharitis or meibomian gland dysfunction limits treatment success regardless of artificial tear selection 5
  • Overreliance on artificial tears alone in moderate to severe disease misses the inflammatory component requiring targeted immunomodulatory treatment 5, 6

Tolerability Profile

  • Systane demonstrates excellent tolerability with median burning, stinging, and blurring scores of 0 on a 0-10 scale 7
  • The majority of patients across all dry eye subtypes report tolerability scores in the 0-5 range for all assessment components 7
  • The pH-sensitive gelling mechanism provides comfort without significant visual blur compared to traditional viscous formulations 2, 3

References

Research

Systane lubricant eye drops in the management of ocular dryness.

Clinical ophthalmology (Auckland, N.Z.), 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dry Eye Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lubricant with gelling agent in treating dry eye in adult Chinese patients.

Optometry and vision science : official publication of the American Academy of Optometry, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.